Clinical trial Recruiting at 8 sites Phase 2 Interventional Ages 18 and up Women only

Managing joint pain in breast cancer survivors

Official title: Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors

Run by Memorial Sloan Kettering Cancer Center · NCT06728579 · Data updated 2026-11-12

This study tests whether two different group therapy approaches can help breast cancer survivors manage joint pain from their medication and improve their overall well-being.

More Cancer Survivor trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment200 (estimated)
SponsorMemorial Sloan Kettering Cancer Center
Academic / other
Drugs / interventionschemotherapy, radiation
Locations9 sites (San Diego, California and 8 other locations)
StatusRecruiting
StartedDecember 6, 2024
Main results expectedDecember 2028
Study endsDecember 2028
Registry record updatedSeptember 22, 2026
Trial IDNCT06728579 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-proficient women aged 18 and older with a history of stage I, II, or III breast cancer who are experiencing joint pain related to aromatase inhibitor therapy.

Probably not a fit

Patients with metastatic breast cancer or those who have recently completed chemotherapy, surgery, or radiation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares two types of group therapy to help breast cancer survivors manage joint pain caused by aromatase inhibitors. Participants will engage in weekly 2-hour sessions over 8 weeks, focusing on either Mindfulness Oriented Recovery Enhancement or Supportive Psychotherapy. The study aims to assess the impact of these therapies on pain, fatigue, anxiety, and overall quality of life, as well as the participants' ability to continue their medication regimen. Data will be collected through questionnaires to evaluate the effectiveness of each approach.

Why it matters

Potential benefit: If successful, this study could provide effective coping strategies for managing joint pain, improving the quality of life for breast cancer survivors.

How similar studies have gone: Other studies have shown promise in using mindfulness and supportive therapies for pain management, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* English-proficient women with a history of stage I, II, or III breast cancer
* Free of oncologic disease by clinical examination and history;
* Receiving third-generation AI therapy (anastrozole, letrozole, or exemestane) for at least 28 days prior to consent with plan to continue for at least another 12 months;
* Worst joint pain rated at least 4 or greater on a 0-10 numeric rating scale in the preceding week prior to consent;
* Reporting at least 15 days with pain in the preceding 30 days prior to consent;
* Experiencing joint pain for at least one month;
* Pain attributed to AI therapy;
* Willing to adhere to all study-related procedures, including randomization to one of two treatment arms: Mindfulness-Oriented Recovery Enhancement (MORE) or Supportive Group Psychotherapy (SG);
* Able to attend video-call sessions in a quiet/private location.

Exclusion Criteria:

* Metastatic breast cancer (stage IV);
* Completed chemotherapy, surgery, or radiation therapy less than 4 weeks prior to enrollment;
* Pain attributed to inflammatory arthritis (i.e. rheumatoid arthritis, gout, pseudogout);
* Surgery or joint injection involving the affected joints within the last month or planned within the next six months;
* Active suicidality or psychosis as determined by the Mini-International Neuropsychiatric Interview.

Where it's running

  • University of California San Diego (Data collection and Data analysis)
    San Diego, California, United States
    Recruiting
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
    Basking Ridge, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Monmouth (All Protocol Activities)
    Middletown, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Bergen (All Protocol Activities)
    Montvale, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities)
    Commack, New York, United States
    Recruiting
  • Memorial Sloan Kettering Westchester (All Protocol Activities)
    Harrison, New York, United States
    Recruiting
Show 3 more locations
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    New York, New York, United States
    Recruiting
  • Memorial Sloan Kettering Nassau (All Protocol Activities)
    Uniondale, New York, United States
    Recruiting
  • Florida State University
    Tallahassee, Florida, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Jun Mao, MD, MSCE — Memorial Sloan Kettering Cancer Center
  • Study coordinator: Jun Mao, MD, MSCE
  • Email: maoj@mskcc.org
  • Phone: 646-608-8553

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.